NOTE 6 - SHAREHOLDERS' EQUITY	3 Months Ended
Mar. 31, 2018
Disclosure Text Block [Abstract]
NOTE 6 - SHAREHOLDERS' EQUITY	NOTE 6 – SHAREHOLDERS’ EQUITY We have authorized capital stock consisting of 100,000,000 shares of $0.0001 par value common stock and 400,000 shares of $0.0001 par value preferred stock. At March 31, 2018 and December 31, 2017, we had 8,034,354 and 3,695,604 shares of common stock issued and outstanding, respectively, and no shares of preferred stock issued and outstanding. During March 2017, the Company recorded a credit to additional paid-in capital of $87,020 for the beneficial conversion feature described in Note 5. During the quarter ended March 31, 2018, the Company issued 338,750 shares of common stock to investors at $0.40 per share for cash totaling $135,500. On March 2, 2018, the Company issued 2,000,000 shares of common stock for $0.01 per share for a total of $20,000. These shares were issued to Mark Mersman and Scott Cox upon exercise of stock options. On March 5, 2018, the Company issued 2,000,000 shares of common stock as part of the asset purchase agreement described in Note 4. Due to Elevated Portfolio Holdings being a related party, the net assets acquired were recorded at predecessor cost.

NOTE 6 - SHAREHOLDERS' EQUITY

3 Months Ended

Mar. 31, 2018

NOTE 6 – SHAREHOLDERS’ EQUITY

We have authorized capital stock consisting of 100,000,000 shares of $0.0001 par value common stock and 400,000 shares of $0.0001 par value preferred stock. At March 31, 2018 and December 31, 2017, we had 8,034,354 and 3,695,604 shares of common stock issued and outstanding, respectively, and no shares of preferred stock issued and outstanding.

During March 2017, the Company recorded a credit to additional paid-in capital of $87,020 for the beneficial conversion feature described in Note 5.

During the quarter ended March 31, 2018, the Company issued 338,750 shares of common stock to investors at $0.40 per share for cash totaling $135,500.

On March 2, 2018, the Company issued 2,000,000 shares of common stock for $0.01 per share for a total of $20,000. These shares were issued to Mark Mersman and Scott Cox upon exercise of stock options.

On March 5, 2018, the Company issued 2,000,000 shares of common stock as part of the asset purchase agreement described in Note 4. Due to Elevated Portfolio Holdings being a related party, the net assets acquired were recorded at predecessor cost.